SCHEMBL3076554

SCHEMBL3076554

COc1nnc(C)c(Cc2ccc(Cl)cc2)c1-c1c(F)cc(F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.36
RORC P51449 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC2A1 P11166 1/20 0.32
NPC1 O15118 1/20 0.32
APLNR P35414 1/20 0.32
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3063211 0.85 KMT2A (0.38) KMT2AMEN1NPSR1KDM4EPOLB
SCHEMBL3074091 0.82 KMT2A (0.36) KMT2AMEN1KDM4EPOLBMAPT
SCHEMBL3067257 0.81 NPSR1 (0.41) KMT2AMEN1MAPK1NPSR1KDM4E
SCHEMBL2355414 0.80 MEN1 (0.47) KMT2AMEN1NPSR1KDM4EMAPT
SCHEMBL3060845 0.77 AR (0.32) KMT2AMEN1NPSR1MAPTALDH1A1
SCHEMBL3070730 0.74 LMNA (0.44) KMT2AMEN1MAPTLMNASLC2A1
SCHEMBL3066117 0.73 NPSR1 (0.41) KMT2AMEN1MAPK1NPSR1MAPT
SCHEMBL3572622 0.73 MEN1 (0.38) KMT2AMEN1NPSR1KDM4EMAPT
SCHEMBL3068585 0.73 PTGS1 (0.39) NPSR1POLBALDH1A1HPGDSMN1; SMN2
SCHEMBL3053121 0.72 CCR2 (0.38) KMT2AMEN1KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100273804-A1 PYRIDAZINE DERIVATIVES USEFUL AS FUNGICIDES AND FOR THE TREATMENT OF CANCER SYNGENTA CROP PROTECTION, INC. (US) 2010-10-28 US disclosed
EP-2220051-A1 PYRIDAZINE DERIVATIVES USEFUL AS FUNGICIDES AND FOR THE TREATMENT OF CANCER Syngenta Participations AG (CH) 2010-08-25 EP disclosed
WO-2009080314-A1 PYRIDAZINE DERIVATIVES USEFUL AS FUNGICIDES AND FOR THE TREATMENT OF CANCER SYNGENTA PARTICIPATIONS AG (CH) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273804-A1 PYRIDAZINE DERIVATIVES USEFUL AS FUNGICIDES AND FOR THE TREATMENT OF CANCER C3AR1, CBR3, C1S KMT2A 3241/4885MEN1 185/4885MAPK1 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.